JAK-IN-5

JAK-IN-5

• CAS Number: 2096999-92-5
• UNSPSC Description: JAK-IN-5 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283.
• Target Antigen: JAK
• Type: Reference compound
• Related Pathways: Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/JAK_inhibitor_1.html
• Solubility: 10 mM in DMSO
• Smiles: CN1CCC(N2CC(N=C(C3=NNC4=C3C=CC(C5=C(CC)C=C(O)C(F)=C5)=C4)N6)=C6CC2)CC1
• Molecular Weight: 474.57
• References & Citations: [1]Paul R. Fatheree, et al. JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease. US20170121327A1|[2]Venkat R, et al. Methods of treatment using a jak inhibitor compound. US20180311226.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported